Fulgent Genetics (FLGT) Gains from Investment Securities (2015 - 2026)
Fulgent Genetics' (FLGT) quarterly Gains from Investment Securities came in at $195000.0 in Q1 2026, up 1028.57% year-on-year from $17278.5 in Q1 2025, and down 65.05% quarter-over-quarter from $558000.0 in Q4 2025.
Fulgent Genetics (FLGT) Gains from Investment Securities (2015 - 2026) Analysis & Trends
Fulgent Genetics has disclosed Gains from Investment Securities across 12 years of filings, most recently posting $195000.0 for Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $195000.0, up 1028.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $195000.0 (up 107.57% YoY), and the FY2025 annual result was $700000.0, down 38.7% from the prior year.
- Gains from Investment Securities came in at $195000.0 for Q1 2026 at Fulgent Genetics, down from $558000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $558000.0 in Q4 2025 to a low of -$2.1 million in Q4 2024.
- The 5-year median for Gains from Investment Securities is $13000.0 (2023), against an average of -$142117.6.
- Across the five-year window, Gains from Investment Securities slumped 2330.77% in 2024 and jumped 1028.57% in 2026, its largest moves.
- Fulgent Genetics' Gains from Investment Securities stood at -$744000.0 in 2022, then surged by 118.55% to $138000.0 in 2023, then slumped by 1631.16% to -$2.1 million in 2024, then surged by 126.41% to $558000.0 in 2025, then plunged by 65.05% to $195000.0 in 2026.
- The last three Gains from Investment Securities figures came in at $195000.0 (Q1 2026), $558000.0 (Q4 2025), and $18000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Fulgent Genetics | 584.27 Mn | 302.31 Mn | 21.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 195,000.00 |
| Mar 31, 2026 | 195,000.00 |
| Dec 31, 2025 | 558,000.00 |
| Dec 31, 2025 | 558,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Mar 31, 2025 | -21,000.00 |
| Mar 31, 2025 | -21,000.00 |
| Dec 31, 2024 | -2.11 Mn |
| Dec 31, 2024 | -2.11 Mn |
| Sep 30, 2024 | 18,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Jun 30, 2024 | 26,000.00 |
| Jun 30, 2024 | 26,000.00 |
| Mar 31, 2024 | -580,000.00 |
| Mar 31, 2024 | -580,000.00 |
| Dec 31, 2023 | 138,000.00 |
| Dec 31, 2023 | 138,000.00 |